Effects of oral contraceptives plus orlistat in patients with polycystic ovary syndrome and overweight/obesity: A meta‐analysis

Aim This meta‐analysis was conducted to compare the effect and safety of oral contraceptive pills (OCP) plus orlistat with OCP alone in clinical, hormonal, and lipid metabolism outcomes in patients with polycystic ovary syndrome (PCOS) and overweight/obesity. Methods Pubmed, Embase, Web of Science,...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The journal of obstetrics and gynaecology research 2022-06, Vol.48 (6), p.1399-1408
Hauptverfasser:	Chen, Zhangming, Cai, Zhaowei
Format:	Artikel
Sprache:	eng
Schlagworte:	Body weight Contraceptives, Oral, Combined - pharmacology Contraceptives, Oral, Combined - therapeutic use Female Follicle-stimulating hormone High density lipoprotein Humans Insulin Insulins - therapeutic use Lipid metabolism Lipids Low density lipoprotein Meta-analysis Metabolism Obesity Obesity - metabolism oral contraceptive pills Oral contraceptives orlistat Orlistat - pharmacology Orlistat - therapeutic use Ovaries Overweight Overweight - complications Overweight - drug therapy Ovulation Patients Polycystic ovary syndrome Polycystic Ovary Syndrome - complications Pregnancy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!